Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Schering Medicaid Settlement Highlights Liability In Disease Management

Executive Summary

Schering-Plough's settlement of kickback charges related to Claritin managed care contracts illustrates the liability associated with company-sponsored disease management agreements

You may also be interested in...



Schering Subsidiary Takes Fall For Criminal Charges Under DoJ Settlement

Schering-Plough's settlement of off-label promotion and Medicaid fraud charges with the Boston U.S. Attorney's office places criminal responsibility with a Schering shell subsidiary

Schering Integrity Agreement Enhances Off-Label Promotion Monitoring

Schering-Plough will be required to implement new monitoring programs to identify and correct potential off-label promotion of certain products by its specialty field sales representatives under an addendum to a 2004 corporate integrity agreement with the HHS Office of Inspector General

Schering Integrity Agreement Enhances Off-Label Promotion Monitoring

Schering-Plough will be required to implement new monitoring programs to identify and correct potential off-label promotion of certain products by its specialty field sales representatives under an addendum to a 2004 corporate integrity agreement with the HHS Office of Inspector General

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044485

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel